David Nicholson - Gilde Healthcare

team
Venture&Growth

All team members
David Nicholson
Operational Partner
United States of America

David Nicholson

Operational Partner

David Nicholson is a recognized leader in Pharmaceutical R&D. Most recently he served as Executive Vice President and Chief R&D Officer of Allergan. Previously, he served as Chief Technology Officer and EVP, R&D for a division at Bayer; Vice President of Licensing and Knowledge Management at Merck; and Senior Vice President, responsible for Global Project Management and Drug Safety at Schering-Plough. From 1988 to 2007, Dr. Nicholson held various leadership positions at Organon, where he most recently served as Executive Vice President, Research & Development and was a member of the company’s Executive Management Committee. He received a B.Sc. from the University of Manchester and his Ph.D. from the University of Wales.

Renée van der Ven

Business Support Manager
Renée van der Ven joined Gilde Healthcare in 2017. She is responsible for Office Management within Gilde and supports the team members of Gilde Healthcare funds in the field of project management and event management....

Arthur Franken

General Partner Healthtech/Therapeutics
Venture&Growth
Arthur Franken joined Gilde in 2001 and was part of the founding team of Gilde Healthcare. He is focusing on venture and growth capital investments in the biopharm, medtech, diagnostics and digital health sectors. He...

Pommeline Korstanje

Analyst
Venture&Growth
Pommeline Korstanje joined Gilde Healthcare in 2024. She is involved in deal sourcing, due diligence, and portfolio management as part of the HealthTech team. She completed her master's degree in Innovation Sciences from Utrecht University,...